Literature DB >> 32870969

Ponatinib coronary microangiopathy: novel bedside diagnostic approach and management with N-acetylcysteine.

Melinda D Wu1, James Hodovan2, Kris Kumar2, Bart Moulton3, Sven Olson3, Aubre Gilbert4, Matthew D Wood4, Jonathan R Lindner2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32870969      PMCID： PMC7479961          DOI： 10.1182/bloodadvances.2020002644

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  13 in total

1.  Pharmacokinetics and pharmacodynamics of AR9281, an inhibitor of soluble epoxide hydrolase, in single- and multiple-dose studies in healthy human subjects.

Authors:  Dawn Chen; Randall Whitcomb; Euan MacIntyre; Vinh Tran; Zung N Do; James Sabry; Dinesh V Patel; Sampath K Anandan; Richard Gless; Heather K Webb
Journal:  J Clin Pharmacol       Date:  2011-03-21       Impact factor: 3.126

2.  Treatment of refractory thrombotic thrombocytopenic purpura with N-acetylcysteine: a case report.

Authors:  Gloria W Li; Siayareh Rambally; Jasmine Kamboj; Sean Reilly; Joel L Moake; Mark M Udden; Martha P Mims
Journal:  Transfusion       Date:  2013-10-09       Impact factor: 3.157

3.  Coronary Microvascular Dysfunction by Myocardial Contrast Echocardiography in Nonelderly Patients Referred for Computed Tomographic Coronary Angiography.

Authors:  Sahar Taqui; Maros Ferencik; Brian P Davidson; J Todd Belcik; Federico Moccetti; Michael Layoun; Jacob Raber; Mitchell Turker; Hagai Tavori; Sergio Fazio; Jonathan R Lindner
Journal:  J Am Soc Echocardiogr       Date:  2019-05-15       Impact factor: 5.251

4.  N-acetylcysteine in preclinical mouse and baboon models of thrombotic thrombocytopenic purpura.

Authors:  Claudia Tersteeg; Jan Roodt; Walter J Van Rensburg; Charlotte Dekimpe; Nele Vandeputte; Inge Pareyn; Aline Vandenbulcke; Barbara Plaimauer; Seb Lamprecht; Hans Deckmyn; José A Lopez; Simon F De Meyer; Karen Vanhoorelbeke
Journal:  Blood       Date:  2016-12-23       Impact factor: 22.113

5.  N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice.

Authors:  Junmei Chen; Adili Reheman; Francisca C Gushiken; Leticia Nolasco; Xiaoyun Fu; Joel L Moake; Heyu Ni; José A López
Journal:  J Clin Invest       Date:  2011-01-25       Impact factor: 14.808

6.  Ponatinib efficacy and safety in Philadelphia chromosome-positive leukemia: final 5-year results of the phase 2 PACE trial.

Authors:  Jorge E Cortes; Dong-Wook Kim; Javier Pinilla-Ibarz; Philipp D le Coutre; Ronald Paquette; Charles Chuah; Franck E Nicolini; Jane F Apperley; H Jean Khoury; Moshe Talpaz; Daniel J DeAngelo; Elisabetta Abruzzese; Delphine Rea; Michele Baccarani; Martin C Müller; Carlo Gambacorti-Passerini; Stephanie Lustgarten; Victor M Rivera; Frank G Haluska; François Guilhot; Michael W Deininger; Andreas Hochhaus; Timothy P Hughes; Neil P Shah; Hagop M Kantarjian
Journal:  Blood       Date:  2018-03-22       Impact factor: 22.113

7.  Oxidative modification of von Willebrand factor by neutrophil oxidants inhibits its cleavage by ADAMTS13.

Authors:  Junmei Chen; Xiaoyun Fu; Yi Wang; Minhua Ling; Brad McMullen; John Kulman; Dominic W Chung; José A López
Journal:  Blood       Date:  2009-10-07       Impact factor: 22.113

8.  Chronic myeloid leukemia: 2020 update on diagnosis, therapy and monitoring.

Authors:  Elias Jabbour; Hagop Kantarjian
Journal:  Am J Hematol       Date:  2020-04-10       Impact factor: 10.047

Review 9.  Tyrosine Kinase Inhibitor-Associated Cardiovascular Toxicity in Chronic Myeloid Leukemia.

Authors:  Javid J Moslehi; Michael Deininger
Journal:  J Clin Oncol       Date:  2015-09-14       Impact factor: 44.544

10.  Thrombotic microangiopathy as a cause of cardiovascular toxicity from the BCR-ABL1 tyrosine kinase inhibitor ponatinib.

Authors:  Yllka Latifi; Federico Moccetti; Melinda Wu; Aris Xie; William Packwood; Yue Qi; Koya Ozawa; Weihui Shentu; Eran Brown; Toshiaki Shirai; Owen J McCarty; Zaverio Ruggeri; Javid Moslehi; Junmei Chen; Brian J Druker; Jose A López; Jonathan R Lindner
Journal:  Blood       Date:  2019-01-28       Impact factor: 25.476
View more
  1 in total

Review 1.  Arterial Thrombotic Complications of Tyrosine Kinase Inhibitors.

Authors:  Melinda D Wu; Javid J Moslehi; Jonathan R Lindner
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-12-04       Impact factor: 8.311
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.